Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 60 2010 039 440.9 |
96 | EP file number | EAKZ | 15 15 1581.4 |
97 | EP publication number | EPN | 2894231 |
54 | Designation/title | TI | Ansprechempfindlichkeit auf Angiogenesehemmer |
51 | IPC main class | ICM (ICMV) | C12Q 1/68 (2018.01) |
22 | DE application date | DAT | Aug 3, 2010 |
96 | EP application date | EAT | Aug 3, 2010 |
43 | Date of first publication | OT | Jul 15, 2015 |
| Date of publication of grant | PET | Jan 4, 2017 |
71/73 | Applicant/owner | INH | F. Hoffmann-La Roche AG, Basel, CH; Life Sciences Research Partners VZW, Leuven, BE; VIB VZW, Gent, BE |
72 | Inventor | IN | Foernzler, Dorothee, 5600 Lenzburg, CH; Delmar, Paul, 4057 Basel, CH; Scherer, Stefan, 4053 Basel, CH; Lambrechts, Diether, 3010 Kessel-Io, BE; Carmeliet, Peter, 3052 Blanden, BE |
| Address for service | | F. Hoffmann-La Roche AG, 4070 Basel, CH |
33 31 32
| Foreign priority | PRC PRNA PRDA
| EP 09167184 Aug 4, 2009
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000002894231 Searchable text:
EP000002894231 Original document:
EP000002894231B1 Searchable text:
EP000002894231B1 |
43 | Date of first publication | EVT | Jul 15, 2015 |
| Date of the first transfer into DPMAregister | EREGT | Jul 16, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 19, 2019 (Show all update days)(Hide all update days)- Aug 19, 2019; Jul 11, 2019; May 9, 2018; Apr 17, 2018; Dec 14, 2017; Nov 30, 2017; Sep 7, 2017; Mar 1, 2017; Jan 18, 2017; Jan 5, 2017
- Historical data not available for this/these date(s)
- Jul 16, 2015
- Date of the first transfer into DPMAregister
|